Biotime-Geron Deal Attracts Interest from Brit Investor
A British investment trust that has invested in Geron says it is going to take an advantage of an offerby an Alameda firm that is seeking to acquire Geron's human embryonic stem cell assets.
Jonathan C. Woolf, managing directorof British & American Investment Trust PLC, said last week in a letter to its shareholders that it is disappointed in Geron's per…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.